Skip to main content
Clinical Trials/NCT06723314
NCT06723314
Completed
Not Applicable

Evaluation of Patient Morbidity and Root Coverage Outcomes of Vestibular Incision Sub Periosteal Tunnel Access Versus Coronally Advanced Flap in Treating Gingival Recession in Esthetic Zone, Randomized Clinical Trial

Misr International University1 site in 1 country30 target enrollmentJanuary 15, 2018
ConditionsEsthetic Zone

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Esthetic Zone
Sponsor
Misr International University
Enrollment
30
Locations
1
Primary Endpoint
Pain Score
Status
Completed
Last Updated
last year

Overview

Brief Summary

To evaluate and compare Vestibular Incision Subperiosteal Tunnel Access (VISTA) technique,with connective tissue graft; versus Coronally Advanced Flap (CAF) technique;with connective tissue graft, in treating gingival recession in esthetic zone. Patients and Methods: Thirty patients, with Miller class I or class II gingival recession, were included in the current study, with age range from 18 to 55 years. Defects were treated using either VISTA combined with connective tissue graft technique, or CAF combined with connective tissue technique. Post-operative discomfort was evaluated using the Visual Analog Scale (VAS) to assess patient morbidity. At baseline, 3, 6 and 9 months, clinical parameters were assessed; Probing Depth (PD), Clinical Attachment Level (CAL), Gingival recession Height (GH), Keratinized Tissue Height (KTH), while Complete and Mean Root Coverage (CRC, MRC) were recorded after nine months. Results: The present study revealed that VISTA showed higher significant difference in pain.VISTA also showed a more reduction in PD, CAL, GH as well as KTH than that of CAF with no significant difference between either of the groups.

Detailed Description

To evaluate and compare Vestibular Incision Subperiosteal Tunnel Access (VISTA) technique,with connective tissue graft; versus Coronally Advanced Flap (CAF) technique;with connective tissue graft, in treating gingival recession in esthetic zone. Patients and Methods: Thirty patients, with Miller class I or class II gingival recession, were included in the current study, with age range from 18 to 55 years. Defects were treated using either VISTA combined with connective tissue graft technique, or CAF combined with connective tissue technique. Post-operative discomfort was evaluated using the Visual Analog Scale (VAS) to assess patient morbidity. At baseline, 3, 6 and 9 months, clinical parameters were assessed; Probing Depth (PD), Clinical Attachment Level (CAL), Gingival recession Height (GH), Keratinized Tissue Height (KTH), while Complete and Mean Root Coverage (CRC, MRC) were recorded after nine months. Results: The present study revealed that VISTA showed higher significant difference in pain.VISTA also showed a more reduction in PD, CAL, GH as well as KTH than that of CAF with no significant difference between either of the groups. Conclusions: Based on the results of the current study, it can be concluded that both techniques allow improvement in root coverage with no significant differences between them, while VISTA technique showed more pain scores by the VAS than that of CAF technique.

Registry
clinicaltrials.gov
Start Date
January 15, 2018
End Date
October 15, 2020
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age between 18- 55 years
  • No sexual discrepancy
  • Medically free
  • Good oral hygeine
  • Sound teeth with single (measuring ≥ 2 mm) or Multiple (measuring ≥ 1 mm)
  • Class I or II gingival recession defects and adequate amount of keratinized tissue (3mm width).

Exclusion Criteria

  • Patients on anticoagulants, antiplatelets, or glucocorticoids.
  • Pregnant females or lactating female patients
  • Smoking patients.
  • Patients with parafunctional habits.
  • Tooth extraction in the surgical sites, active periodontal disease or history of previous surgery in the same area.

Outcomes

Primary Outcomes

Pain Score

Time Frame: 1-10 days

Visual Analogue Scale to measure pain from (0-10) with 0 (no pain) and 10 (worst pain)

Study Sites (1)

Loading locations...

Similar Trials